Clinical Trial Update: To Evaluate the Efficacy and Safety of HSK16149 Capsule in Chinese Patients With Postherpetic Neuralgia [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating HSK16149 capsule for efficacy and safety in Chinese patients with postherpetic neuralgia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postherpetic Neuralgia

Drugs mentioned

• HSK16149

Snippet

Sponsor: Haisco Pharmaceutical Group Co., Ltd. | Conditions: Postherpetic Neuralgia | Phase 3 | Status: COMPLETED